Johanna Goldfarb
Johanna Goldfarb has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Stephanie Yee-Guardino
Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, Ohio
3 shared publicationsCamille Sabella
Cleveland Clinic Children’s Hospital, Cleveland, Ohio, USACleveland Clinic, Cleveland, Ohio, USA
2 shared publicationsDebra Kohn
Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio
2 shared publicationsLara Danziger-Isakov
Pediatric Infectious Diseases, Cleveland Clinic Children's Hospital, Cleveland, Ohio
2 shared publications- Philip E. Pellett
Wayne State University, Detroit, Michigan, USA
2 shared publications Sarah Worley
Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio
2 shared publications
Latest Publications
- 17 June 2021
- Published by Taylor & Francis in Journal of Health Care Chaplaincy
- Vol. 28 (3) , 378-399
Teaching spirituality to medical students: a systematic review
Though it has become increasingly clear that religion and spirituality are important aspects of whole patient care, little is known about how this topic is taught to medical students. This systemat...
- 17 June 2021
- Published by Taylor & Francis in Journal of Health Care Chaplaincy
- Vol. 28 (3) , 378-399
Teaching spirituality to medical students: a systematic review
Though it has become increasingly clear that religion and spirituality are important aspects of whole patient care, little is known about how this topic is taught to medical students. This systemat...
- 1 June 2019
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 86 (6) , 393-398
Measles: A dangerous vaccine-preventable disease returns
Release date: June 1, 2019Expiration date: May 31, 2020Estimated time of completion: 1 hourClick here to start this CME/MOC activity.ABSTRACTAlthough a safe and effective vaccine has been available for over 6 decades, vaccine hesitancy in the United States and social and political unrest globally have led to undervaccination. As a result, in recent months, vaccine control of measles has been threatened with an alarming upswing in measles cases nationally and internationally. Here, we review the disease and its management in view of recent outbreaks.
- 1 June 2019
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 86 (6) , 393-398
Measles: A dangerous vaccine-preventable disease returns
Release date: June 1, 2019Expiration date: May 31, 2020Estimated time of completion: 1 hourClick here to start this CME/MOC activity.ABSTRACTAlthough a safe and effective vaccine has been available for over 6 decades, vaccine hesitancy in the United States and social and political unrest globally have led to undervaccination. As a result, in recent months, vaccine control of measles has been threatened with an alarming upswing in measles cases nationally and internationally. Here, we review the disease and its management in view of recent outbreaks.
- 27 January 2016
- Published by Wiley in Journal of Medical Virology
- Vol. 88 (8) , 1427-1437
Absence of human herpesvirus 6B detection in association with illness in children undergoing cancer chemotherapy
The lymphotropic herpesviruses, cytomegalovirus (CMV), Epstein-Barr virus (EBV), and human herpesvirus 6B (HHV-6B) can reactivate and cause disease in organ transplant recipients; the contributions of HHV-6A and HHV-7 to disease are less certain. Less is known about their pathogenic roles in children undergoing treatment for malignancies. Children with newly diagnosed cancer were followed for 24 months. Clinical information and blood samples were collected during routine visits and during acute visits for fever or possible viral infections. Lymphotropic herpesvirus DNA in blood was measured by polymerase chain reaction (PCR). Although HHV-6B DNA was detected at least once in about half of the patients; the other viruses were seldom detected. There was no association between HHV-6B detection and individual acute clinical events, however, HHV-6B detection was more common in children who experienced more frequent acute clinical events. In children being treated for various malignancies, HHV-6B detection was common, but was not associated with individual events of acute illness. Thus, if HHV-6B is not assessed longitudinally, clinical events may be misattributed to the virus. The elevated frequency of detection of HHV-6B in sicker children is consistent with prior reports of its detection during apparently unrelated acute clinical events. J. Med. Virol. 88:1427–1437, 2016.
- 27 January 2016
- Published by Wiley in Journal of Medical Virology
- Vol. 88 (8) , 1427-1437
Absence of human herpesvirus 6B detection in association with illness in children undergoing cancer chemotherapy
The lymphotropic herpesviruses, cytomegalovirus (CMV), Epstein-Barr virus (EBV), and human herpesvirus 6B (HHV-6B) can reactivate and cause disease in organ transplant recipients; the contributions of HHV-6A and HHV-7 to disease are less certain. Less is known about their pathogenic roles in children undergoing treatment for malignancies. Children with newly diagnosed cancer were followed for 24 months. Clinical information and blood samples were collected during routine visits and during acute visits for fever or possible viral infections. Lymphotropic herpesvirus DNA in blood was measured by polymerase chain reaction (PCR). Although HHV-6B DNA was detected at least once in about half of the patients; the other viruses were seldom detected. There was no association between HHV-6B detection and individual acute clinical events, however, HHV-6B detection was more common in children who experienced more frequent acute clinical events. In children being treated for various malignancies, HHV-6B detection was common, but was not associated with individual events of acute illness. Thus, if HHV-6B is not assessed longitudinally, clinical events may be misattributed to the virus. The elevated frequency of detection of HHV-6B in sicker children is consistent with prior reports of its detection during apparently unrelated acute clinical events. J. Med. Virol. 88:1427–1437, 2016.
- 1 July 2014
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 4 (4) , 233-238
The Harada Score in the US Population of Children With Kawasaki Disease
Objective: To describe and quantify the presentations of Kawasaki disease (KD) in a children’s hospital over 10 years to assess the Harada score in a US population. Methods: A retrospective chart review from 2001 to 2011 of children discharged from Cleveland Clinic with the diagnosis of KD. Demographic and clinical data were collected and Harada scores were derived to evaluate efficacy in predicting risk for coronary artery aneurysms (CAAs). Results: A total of 105 children met diagnostic criteria for KD, and 97 of 105 had long-term follow-up. Full criteria for KD were found in 67 of 105 (64%); 38 had incomplete presentations. CAA developed in 10 children, 5 during follow-up despite treatment with intravenous immunoglobulin (IVIG.) Children with incomplete presentations had a higher risk of developing CAA (20% vs 5%, P = .03) and a delayed diagnosis (median days from fever to diagnosis 8.0 vs 5.0 days, P < .001). Of children who developed CAA, 9 of 10 had a positive Harada score (sensitivity of 90%). All children who developed CAA after IVIG were in the high-risk group, but 1 child with an incomplete presentation who had a CAA at presentation was missed by the score. Overall, the negative predictive value was 98%. Conclusions: As in Japanese studies, a positive Harada score in a US population could be used to identify a high-risk population for CAA development. All children who developed CAA after treatment with IVIG would have been assigned to a high-risk category. Though not specific enough to select initial therapy, the score might be useful in identifying high-risk children for evaluation of new therapies and more frequent follow-up.
- 1 July 2014
- Published by American Academy of Pediatrics (AAP) in Hospital Pediatrics
- Vol. 4 (4) , 233-238
The Harada Score in the US Population of Children With Kawasaki Disease
Objective: To describe and quantify the presentations of Kawasaki disease (KD) in a children’s hospital over 10 years to assess the Harada score in a US population. Methods: A retrospective chart review from 2001 to 2011 of children discharged from Cleveland Clinic with the diagnosis of KD. Demographic and clinical data were collected and Harada scores were derived to evaluate efficacy in predicting risk for coronary artery aneurysms (CAAs). Results: A total of 105 children met diagnostic criteria for KD, and 97 of 105 had long-term follow-up. Full criteria for KD were found in 67 of 105 (64%); 38 had incomplete presentations. CAA developed in 10 children, 5 during follow-up despite treatment with intravenous immunoglobulin (IVIG.) Children with incomplete presentations had a higher risk of developing CAA (20% vs 5%, P = .03) and a delayed diagnosis (median days from fever to diagnosis 8.0 vs 5.0 days, P < .001). Of children who developed CAA, 9 of 10 had a positive Harada score (sensitivity of 90%). All children who developed CAA after IVIG were in the high-risk group, but 1 child with an incomplete presentation who had a CAA at presentation was missed by the score. Overall, the negative predictive value was 98%. Conclusions: As in Japanese studies, a positive Harada score in a US population could be used to identify a high-risk population for CAA development. All children who developed CAA after treatment with IVIG would have been assigned to a high-risk category. Though not specific enough to select initial therapy, the score might be useful in identifying high-risk children for evaluation of new therapies and more frequent follow-up.
- Open Access
- 1 April 2008
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 14 (4) , 579-585
β-Herpesviruses in Febrile Children with Cancer
We conducted a cross-sectional study of β-herpesviruses in febrile pediatric oncology patients (n = 30), with a reference group of febrile pediatric solid-organ transplant recipients (n = 9). One (3.3%) of 30 cancer patients and 3 (33%) of 9 organ recipients were PCR positive for cytomegalovirus. Four (13%) of 30 cancer patients and 3 (33%) of 9 transplant recipients had human herpesvirus 6B (HHV-6B) DNAemia, which was more common within 6 months of initiation of immune suppression (4 of 16 vs. 0 of 14 cancer patients; p = 0.050). HHV-6A and HHV-7 were not detected. No other cause was identified in children with HHV-6B or cytomegalovirus DNAemia. One HHV-6B–positive cancer patient had febrile disease with concomitant hepatitis. Other HHV-6B–positive children had mild “viral” illnesses, as did a child with primary cytomegalovirus infection. Cytomegalovirus and HHV-6B should be included in the differential diagnosis of febrile disease in children with cancer.
- 1 April 2008
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 14 (4) , 579-585
Open Accessβ-Herpesviruses in Febrile Children with Cancer
We conducted a cross-sectional study of β-herpesviruses in febrile pediatric oncology patients (n = 30), with a reference group of febrile pediatric solid-organ transplant recipients (n = 9). One (3.3%) of 30 cancer patients and 3 (33%) of 9 organ recipients were PCR positive for cytomegalovirus. Four (13%) of 30 cancer patients and 3 (33%) of 9 transplant recipients had human herpesvirus 6B (HHV-6B) DNAemia, which was more common within 6 months of initiation of immune suppression (4 of 16 vs. 0 of 14 cancer patients; p = 0.050). HHV-6A and HHV-7 were not detected. No other cause was identified in children with HHV-6B or cytomegalovirus DNAemia. One HHV-6B–positive cancer patient had febrile disease with concomitant hepatitis. Other HHV-6B–positive children had mild “viral” illnesses, as did a child with primary cytomegalovirus infection. Cytomegalovirus and HHV-6B should be included in the differential diagnosis of febrile disease in children with cancer.
- 21 June 2006
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 27 (6) , 630-632
Nosocomially AcquiredPseudomonas stutzeriBrain Abscess in a Child: Case Report and Review
Pseudomonas stutzeriis a rare cause of nosocomial infection. We report a pediatric case of nosocomially acquiredP. stutzeribrain abscess after subdural grid implantation before surgery for refractory epilepsy and review the literature.
- 21 June 2006
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 27 (6) , 630-632
Nosocomially AcquiredPseudomonas stutzeriBrain Abscess in a Child: Case Report and Review
Pseudomonas stutzeriis a rare cause of nosocomial infection. We report a pediatric case of nosocomially acquiredP. stutzeribrain abscess after subdural grid implantation before surgery for refractory epilepsy and review the literature.
- 1 February 2002
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 69 (2) , 153-154
What is the best way to diagnose streptococcal pharyngitis?
- 1 February 2002
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 69 (2) , 153-154
What is the best way to diagnose streptococcal pharyngitis?